Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (51-60 of 218) with videos related to

Pageof 22
Sort By:
Annals of Gastroenterology|July 7, 2020
Advances in the endoscopic management of malignant biliary obstructionThomas Thomaidis, George Kallimanis, Gary May, et al.
Oncology Research and Treatment|February 28, 2018
External Validation of the Proposed Kiel Staging System and Comparison with the Old (6th Edition) and the Currently Used (7th Edition) TNM Classification in Gastric CancerOrestis Lyros, Thomas Thomaidis, Manuel Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2022
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinomaMarkus Moehler, Anica Högner, Anna D Wagner, et al.
BMC Cancer|October 28, 2011
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1Markus Moehler, Maike Sieben, Susanne Roth, et al.
International Journal of Colorectal Disease|November 26, 2009
K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancerCarl C Schimanski, Tim Zimmermann, Irene Schmidtmann, et al.
Journal of Medicinal Chemistry|October 24, 2012
Novel 3-Azaindolyl-4-arylmaleimides exhibiting potent antiangiogenic efficacy, protein kinase inhibition, and antiproliferative activityChristopher Ganser, Eva Lauermann, Annett Maderer, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 5, 2013
Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Melanie Kripp, Salah-Eddin Al-Batran, Johanna Rosowski, et al.
Frontiers in Oncology|February 22, 2020
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-StudyElizabeth Smyth, Maren Knödler, Anne Giraut, et al.
The Cochrane Database of Systematic Reviews|August 30, 2017
Chemotherapy for advanced gastric cancerAnna Dorothea Wagner, Nicholas Lx Syn, Markus Moehler, et al.
Cancer Research|January 15, 2009
IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53Kerstin Herzer, Thomas G Hofmann, Andreas Teufel, et al.
Pageof 22

Showing results (51-60 of 218) with videos related to

Sort By:
Pageof 22
Annals of Gastroenterology|July 7, 2020
Advances in the endoscopic management of malignant biliary obstructionThomas Thomaidis, George Kallimanis, Gary May, et al.
Oncology Research and Treatment|February 28, 2018
External Validation of the Proposed Kiel Staging System and Comparison with the Old (6th Edition) and the Currently Used (7th Edition) TNM Classification in Gastric CancerOrestis Lyros, Thomas Thomaidis, Manuel Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2022
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinomaMarkus Moehler, Anica Högner, Anna D Wagner, et al.
BMC Cancer|October 28, 2011
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1Markus Moehler, Maike Sieben, Susanne Roth, et al.
International Journal of Colorectal Disease|November 26, 2009
K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancerCarl C Schimanski, Tim Zimmermann, Irene Schmidtmann, et al.
Journal of Medicinal Chemistry|October 24, 2012
Novel 3-Azaindolyl-4-arylmaleimides exhibiting potent antiangiogenic efficacy, protein kinase inhibition, and antiproliferative activityChristopher Ganser, Eva Lauermann, Annett Maderer, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 5, 2013
Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Melanie Kripp, Salah-Eddin Al-Batran, Johanna Rosowski, et al.
Frontiers in Oncology|February 22, 2020
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-StudyElizabeth Smyth, Maren Knödler, Anne Giraut, et al.
The Cochrane Database of Systematic Reviews|August 30, 2017
Chemotherapy for advanced gastric cancerAnna Dorothea Wagner, Nicholas Lx Syn, Markus Moehler, et al.
Cancer Research|January 15, 2009
IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53Kerstin Herzer, Thomas G Hofmann, Andreas Teufel, et al.
Pageof 22